Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pharmacies Should Have Same Right To Import As Manufacturers - NCPA

Executive Summary

Licensed pharmacists should have the same right to import and re-import prescription drugs as manufacturers, the National Community Pharmacists Association maintained in an Aug. 24 letter to the House and Senate conferees on the Agriculture Appropriations bill (HR 4461).

You may also be interested in...



Mexican Rx Counterfeits Should Be Focus Of Public Education - Testimony

A public education effort should highlight the threat of counterfeit drugs imported from Mexico, University of Texas Center for Pharmacoeconomics Director Marv Shepherd, PhD, suggested to the House Commerce/Oversight Subcommittee.

Mexican Rx Counterfeits Should Be Focus Of Public Education - Testimony

A public education effort should highlight the threat of counterfeit drugs imported from Mexico, University of Texas Center for Pharmacoeconomics Director Marv Shepherd, PhD, suggested to the House Commerce/Oversight Subcommittee.

Pharmacia VP Friedman Is Among PhRMA Favorites For FDA Commissioner

Pharmacia Senior VP Michael Friedman's recent letter to the New England Journal of Medicine regarding the use of Cytotec (misoprostol) in pregnant women should help continue his candidacy to return to FDA as commissioner.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS036585

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel